Polyether brevetoxin derivatives as a treatment for cystic fibrosis, mucociliary dysfunction, and pulmonary diseases

Details for Australian Patent Application No. 2004274483 (hide)

Owner University of North Carolina at Wilmington

Inventors Bourdelais, Andrea J.; Baden, Daniel G.; Abraham, William M.

Agent Freehills

Pub. Number AU-B-2004274483

PCT Pub. Number WO2005/028482

Priority 60/504,665 19.09.03 US

Filing date 20 September 2004

Wipo publication date 31 March 2005

Acceptance publication date 7 April 2011

International Classifications

C07D 493/14 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/365 (2006.01) - Lactones

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

A61P 11/12 (2006.01) Drugs for disorders of the respiratory system

C07D 493/22 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/028482 Priority application(s): WO2005/028482

7 April 2011 Application Accepted

  Published as AU-B-2004274483

4 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004274484-Molded plastic gangway

2004274480-Fused pentacyclic polyethers